[{"NetIncomeLossConverted_1_Q2_USD":-29183000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":184344000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":180729000.0,"CommonStockSharesConverted_0_Q2_shares":181148332.0,"Assets_0_Q2_USD":5302110000.0,"RevenuesConverted_2_Q2_USD":931554000.0,"RevenuesConverted_1_Q2_USD":429485000.0,"EarningsPerShareBasic_2_Q2_USD":0.29,"StockholdersEquity_0_Q2_USD":3236679000.0,"EarningsPerShareDiluted_2_Q2_USD":0.28,"EarningsPerShareDiluted_1_Q2_USD":-0.16,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":12543000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":180314000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":180729000.0,"NetIncomeLossConverted_2_Q2_USD":52198000.0,"CommonStockSharesOutstanding_0_Q2_shares":181148332.0,"EarningsPerShareBasic_1_Q2_USD":-0.16,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]